Angelique E Richardson, MD, PHD

Richardson Angelique
Specialties
Breast Medical Oncology
Primary Office
Address 1150 N 35th Avenue
Suite 170
Hollywood, FL 33021
Phone: 954-265-4325

About Me

I am a breast medical oncologist at Memorial Healthcare System. I provide care, support and guidance for patients with breast cancer throughout their diagnosis, cancer treatment and follow-up care.

I began my career working on medical research, which was focused specifically on breast cancer. I became interested in how our research was impacting actual people who were battling cancer. This, along with some close family members who were diagnosed with cancer, made me more interested in the clinical side of cancer care. I decided I wanted to champion people as they battled cancer and care for them throughout their journey.

I focus on each patient as a person - not just his or her diagnosis. My goal is to explain everything that you can expect during your treatment and answer all of your questions. I want my patients to leave my office feeling empowered with information and more at ease.

Cancer can affect many parts of your life and be emotionally overwhelming to deal with. This is normal and we need to address all of your concerns in order to help you feel your best. I focus on what I describe as whole-person care. This means that I am here to assist with anything in regards to your overall wellbeing, whether it is spiritual, physical or mental.

At Memorial, patients are our number one priority. You can rest assured that everyone on our team is here for you. We will walk with you on this journey, support you and be rooting for you every step of the way.

Related Medical Services

Education

Education
  • Loma Linda University School Of Medicine, 2011
Internships
  • White Memorial Medical Center, 2014, Internal Medicine
Fellowships
  • Pennsylvania State Univ College Of Medicine, 2017, Oncology and Hematology
  • University Of Miami-Jackson Memorial Hospital
Certifications
  • American Board of Internal Medicine-Internal Medicine
  • American Board of Internal Medicine-Medical Oncology

Professional Highlights

Professional Organizations

  • American Society of Hematology
  • American Society of Clinical Oncology
  • National Medical Association
  • American College of Physicians
  • American Society of Clinical Oncology
  • American Medical Association

Research

Research has played an important role throughout my medical career. My research interests include breast cancer treatment trials, triple negative breast cancer and health disparities for people with cancer.

Recent projects include:
  • Clinical Trial: A study to document the effects of virtual reality intervention on nausea, vomiting, anxiety and fatigue in underserved breast cancer patients receiving IV chemotherapy at Jackson Memorial Hospital in Miami, Florida. (Currently, undergoing IRB review)
  • A retrospective chart review –A study to document the effect of Obamacare implementation on the stage of disease presentation in breast cancer patients seen at Jackson Memorial Hospital in Miami, Florida. (Completed and currently being written up for publication submission)

Presentations

  • A Ellerbee, CC Casiano, C Brito and Daisy D De Leon. 2007 Genistein and Curcumin Requlate proIGF-II to Promote Apoptosis of ER-/PR- Breast Cancer Cells from African American Patients. 89th Endocrine Society Annual Meeting. June 2007. Toronto, Canada.
  • AP Ellerbee, N. Hamilton and Daisy D De Leon. 2007. IGF-II regulates phosphorylation of estrogen receptors in breast cancer cells from African American patients. AACR Health Disparities meeting. December 2007. Atlanta, Georgia.
  • AP Ellerbee, N. Hamilton and Daisy D De Leon. 2007. IGF-II regulates phosphorylation of estrogen receptors in breast cancer cells from African American patients. AACR annual meeting. April 2007. Los Angeles, CA.
  • AP Ellerbee, N. Hamilton and Daisy D De Leon. 2008. IGF-II regulates phosphorylation of estrogen receptors in breast cancer cells from African American patients. AACR annual meeting. April 2008. San Diego, CA.
  • AP Ellerbee, N. Hamilton and Daisy D De Leon. 2008. IGF-II phosphorylates and activates ER-( and ER-® in African American Breast Cancer Cell Lines. NIH Health Disparities meeting. December 2008. Washington, D.C. 
  • AP Ellerbee, N. Hamilton and Daisy D De Leon. 2009. The role of IGF-II in estrogen independent tumors in African American Breast Cancer Cell Lines. AACR Health Disparities meeting. February 2009. Carefree, Arizona.
  • Ashley Kang, et. Al. and Angelique Richardson. 2016. Effect of serum biomarkers (activin A. CAIZ, HER2, TIMP-1, and uPA) on outcome in HER2+metastatic breast cancer patients treated in first line with lapatinib or trastuzumab combined with taxane. CCTG MA.31.SABCS/CTRC/AACR Breast Cancer Symposium. Dec. 10, 2016.

Related Physicians